Comments
Watson sues FDA on generic diabetes drug ruling
16.08.2012. | (Reuters) - Generic drugmaker Watson Pharmaceuticals Inc sued the U.S. Food and Drug Administration, challenging a ruling against Watson's generic version of a big-selling diabetes drug, Actos....
